Table 3

Bacterial carrier status at the time of intervention

Pathogen% all patients (n=34)% patients with FEV1 <40% pred. (n=13)% non-survivors without lung transplant (n=8)% patients with lung transplant (n=12)% patients with reintervention (n=20)
Pseudomonas aeruginosa79.49287.510080
Staphylococcus aureus including MRSA5061.587.52545
Aspergillus fumigatus47.176.947.166.765
P. aeruginosa and S. aureus35.338.5752540
Achromobacter xylosoxidans26.538.45016.730
  • FEV1% pred., functional end-expiratory volume in 1 s in % predicted; MRSA, methicillin-resistant Staphylococcus aureus.